Related Experiment Video
Updated: Jan 26, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal
Daniel J Coleman1, Lina Gao1, Carly J King1,2
1Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Abstract:
BET bromodomain inhibitors block prostate cancer cell growth at least in part through c-Myc and androgen receptor (AR) suppression. However, little is known about other transcriptional regulators whose suppression contributes to BET bromodomain inhibitor anti-tumor activity. Moreover, the anti-tumor activity of BET bromodomain inhibition in AR-independent castration-resistant prostate cancers (CRPC), whose frequency is increasing, is also unknown. Herein, we demonstrate that BET bromodomain inhibition blocks growth of a diverse set of CRPC cell models, including those that are AR-independent or in which c-Myc is not suppressed. To identify transcriptional regulators whose suppression accounts for these effects, we treated multiple CRPC cell lines with the BET bromodomain inhibitor JQ1 and then performed RNA-sequencing followed by Master Regulator computational analysis. This approach identified several previously unappreciated transcriptional regulators that are highly expressed in CRPC and whose suppression, via both transcriptional or post-translational mechanisms, contributes to the anti-tumor activity of BET bromodomain inhibitors.
Insights
BET bromodomain inhibitors effectively suppress prostate cancer cell growth, including in castration-resistant prostate cancers (CRPC). This study identifies novel transcriptional regulators contributing to this anti-tumor activity.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- BET bromodomain inhibitors suppress prostate cancer (PC) growth via c-Myc and androgen receptor (AR) pathways.
- The role of BET inhibitors in AR-independent castration-resistant prostate cancer (CRPC) remains largely unknown.
- Identification of additional transcriptional regulators targeted by BET inhibitors is needed.
Purpose of the Study:
- To investigate the anti-tumor activity of BET bromodomain inhibition in diverse CRPC models.
- To identify novel transcriptional regulators suppressed by BET inhibitors that contribute to anti-cancer effects.
Main Methods:
- Treatment of multiple CRPC cell lines with the BET bromodomain inhibitor JQ1.
- RNA-sequencing to analyze gene expression changes.
- Master Regulator computational analysis to identify key transcriptional regulators.
Main Results:
- BET bromodomain inhibition demonstrated anti-tumor activity across various CRPC models, including AR-independent and c-Myc-independent cases.
- RNA-sequencing and Master Regulator analysis identified previously unrecognized transcriptional regulators.
- Suppression of these regulators, through transcriptional or post-translational mechanisms, contributes to BET inhibitor efficacy.
Conclusions:
- BET bromodomain inhibition is a promising therapeutic strategy for a broad spectrum of CRPC.
- The study uncovers novel molecular targets and mechanisms underlying BET inhibitor action in prostate cancer.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Network Function of a Circuit
Testosterone: Functions and Regulation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

